Study finds people with blood cancer need more protection against COVID-19, even if vaccinated
UCLA Health Connect blog
People with blood cancer, who already are particularly vulnerable to COVID-19, do not develop strong immunity after vaccination and need additional layers of protection, according to new research led by UCLA Health.
Antoni Ribas, MD, director of the Tumor Immunology Program at the UCLA Jonsson Comprehensive Cancer Center, said of patients with common blood cancers, such as chronic lymphocytic leukemia (CLL) and non-Hodgkins lymphoma, only 40 to 70 percent produced antibodies to fight COVID-19 after vaccination. By comparison, 98 to 100 percent of healthy people developed antibodies.
Click here to read the UCLA Health Connect blog.